Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Discovery: Overview01:26

Drug Discovery: Overview

10.4K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
10.4K
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

129
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
129
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.1K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.1K
Cancer Therapies02:49

Cancer Therapies

2.4K
2.4K
Cancer Therapies02:49

Cancer Therapies

8.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.6K
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

1.1K
1.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Medical research: No catch to UK charity funding.

Nature·2012
Same author

Molecular markers for the assessment of postnatal male germ cell development in the mouse.

Human reproduction (Oxford, England)·2004
Same author

Breast cancer: patients need to be better informed.

Professional nurse (London, England)·2003
Same author

Future developments in assisted reproduction in humans.

Reproduction (Cambridge, England)·2002

Related Experiment Video

Updated: May 6, 2026

Amplification of Near Full-length HIV-1 Proviruses for Next-Generation Sequencing
10:18

Amplification of Near Full-length HIV-1 Proviruses for Next-Generation Sequencing

Published on: October 16, 2018

15.3K

Help us find the cures.

Delyth Morgan

    Breast Cancer Research : BCR
    |November 1, 2013
    PubMed
    Summary

    Breast cancer remains a leading cause of cancer death. A 2013 Gap Analysis identified research needs and five solutions, emphasizing collaboration to prevent, cure, and outlive breast cancer by 2050.

    Area of Science:

    • Oncology
    • Cancer Research

    Background:

    • Breast cancer is the most prevalent cancer in the UK, with 50,000 diagnoses and 12,000 deaths annually.
    • Significant research advances have been made, yet breast cancer remains a critical global health challenge.

    Discussion:

    • A 2013 Gap Analysis highlighted critical knowledge gaps in breast cancer research.
    • The analysis proposed five strategic solutions requiring collaboration between academia, industry, funders, policymakers, healthcare professionals, and patients.
    • Key recommendations include reversing declining research funding, enhancing research infrastructure, fostering multidisciplinary collaboration, and improving clinical trial design.

    Key Insights:

    • Addressing breast cancer requires a unified, collaborative effort across diverse sectors.
    • Strategic solutions focus on filling knowledge gaps and optimizing research processes.

    More Related Videos

    Regulatory T cells: Therapeutic Potential for Treating Transplant Rejection and Type I Diabetes
    16:26

    Regulatory T cells: Therapeutic Potential for Treating Transplant Rejection and Type I Diabetes

    Published on: August 20, 2007

    5.4K
    A High-throughput, High-content, Liquid-based C. elegans Pathosystem
    09:44

    A High-throughput, High-content, Liquid-based C. elegans Pathosystem

    Published on: July 1, 2018

    14.2K

    Related Experiment Videos

    Last Updated: May 6, 2026

    Amplification of Near Full-length HIV-1 Proviruses for Next-Generation Sequencing
    10:18

    Amplification of Near Full-length HIV-1 Proviruses for Next-Generation Sequencing

    Published on: October 16, 2018

    15.3K
    Regulatory T cells: Therapeutic Potential for Treating Transplant Rejection and Type I Diabetes
    16:26

    Regulatory T cells: Therapeutic Potential for Treating Transplant Rejection and Type I Diabetes

    Published on: August 20, 2007

    5.4K
    A High-throughput, High-content, Liquid-based C. elegans Pathosystem
    09:44

    A High-throughput, High-content, Liquid-based C. elegans Pathosystem

    Published on: July 1, 2018

    14.2K
  • Increased and targeted funding is crucial for accelerating progress.

    • Outlook:

    • The goal is to overcome breast cancer by 2050 through concerted, collaborative action.
    • Implementing the identified strategies is essential for achieving significant progress.
    • Urgent action is needed to implement identified solutions and meet the 2050 objective.